A share price of Dexcom Inc [DXCM] is currently trading at $67.39, up 1.89%. An important factor to consider is whether the stock is rising or falling in short-term value. The DXCM shares have gain 9.35% over the last week, with a monthly amount drifted -4.67%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on April 10, 2025, when Mizuho initiated its Outperform rating and assigned the stock a price target of $85. Previously, Redburn Atlantic upgraded its rating to Buy on February 03, 2025, and elevated its price target to $115. On January 16, 2025, upgrade upgraded it’s rating to Outperform and revised its price target to $104 on the stock. Robert W. Baird downgraded its rating to a Neutral and decreased its price target to $80 on July 26, 2024. JP Morgan downgraded its rating to a Neutral and reduced its price target to $75 on July 26, 2024. Redburn Atlantic started tracking with a Neutral rating for this stock on May 30, 2024, and assigned it a price target of $130. In a note dated March 12, 2024, RBC Capital Mkts initiated an Outperform rating and provided a target price of $165 on this stock.
Dexcom Inc experienced fluctuations in its stock price throughout the past year between $57.52 and $139.24. Currently, Wall Street analysts expect the stock to reach $81.36 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $67.39 at the most recent close of the market. An investor can expect a potential return of 20.73% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
Trailing Twelve Months sales for Dexcom Inc [NASDAQ:DXCM] were 4.03B which represents 7.64% growth. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.26 and Total Capital is 0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 66.51 points at the first support level, and at 65.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.17, and for the 2nd resistance point, it is at 68.95.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Dexcom Inc [NASDAQ:DXCM] is 1.47. On the other hand, the Quick Ratio is 1.28, and the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 6.55, the price to book ratio is 12.52 and price to earnings (TTM) ratio is 47.30.
Transactions by insiders
Recent insider trading involved Heller Bridgette P, Director, that happened on Mar 17 ’25 when 352.0 shares were sold. Director, Heller Bridgette P completed a deal on Mar 17 ’25 to buy 352.0 shares. Meanwhile, EVP, Chief Operating Officer Leach Jacob Steven sold 14076.0 shares on Mar 12 ’25.
